比拉斯丁在过敏性鼻炎中的作用:叙述性综述
Mangesh Tiwaskar1, Agam Vora2, Kamlesh Tewary3
1Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra, India, Corresponding Author.
概括
过敏性鼻炎 (AR) 通常被低估,但可能导致喘. 比拉斯丁 (Bilastine) 是一种非镇静性H1抗胰岛素,为AR提供有效和安全的治疗,副作用和药物相互作用最小.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 过敏性鼻炎 (AR) 经常是自我治疗的,尽管它是喘和其他并发症的危险因素.
- 在AR中,炎症主要由组胺介导,需要有效的抗组胺治疗.
- 目前的指导方针建议第二代H1抗组胺剂用于AR治疗,因为它们的安全性.
研究的目的:
- 审查目前对过敏性鼻炎 (AR) 管理的指导方针.
- 综合讨论比拉斯在治疗AR中的作用和疗效.
- 突出比拉斯的药理动力学特征和在不同患者群体中的安全性.
主要方法:
- 关于过敏性鼻炎现有文献和临床指南的叙述性综述.
- 对比拉斯的药理性质的分析,包括受体特异性和药理动力学.
- 评估比拉斯的安全性,耐受性和药物相互作用概况.
主要成果:
- 比拉斯丁对H1受体具有很高的特异性,对其他受体的亲和力很小.
- 它提供了快速,长时间的作用,改善了患者的遵从性,并减少了剂量频率.
- 比拉斯丁耐受性很好,长期不镇静,药物相互作用的可能性很低,因此适合老年患者使用.
结论:
- 比拉斯丁 (Bilastine) 是一种安全有效的第二代H1抗组胺,用于过敏性鼻炎 (AR).
- 其有利的药理动力学特征和最小的不良反应支持其在包括老年人在内的各种患者群体中的使用.
- 根据目前的指导方针,比拉斯代表了在AR管理中一个有价值的治疗选择.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
277
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
252
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
252
01:19Antiasthma Drugs: Leukotriene Modifiers
281
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
281
01:20Asthma: Pathogenesis and Management
389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
239
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
239
01:17Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424